“Omics”-Informed Drug and Biomarker Discovery: Opportunities, Challenges and Future Perspectives
The pharmaceutical industry faces unsustainable program failure despite significant increases in investment. Dwindling discovery pipelines, rapidly expanding R&D budgets and increasing regulatory control, predict significant gaps in the future drug markets. The cumulative duration of discovery f...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2016-09-01
|
| Serie: | Proteomes |
| Soggetti: | |
| Accesso online: | http://www.mdpi.com/2227-7382/4/3/28 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|